Related references
Note: Only part of the references are listed.Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
Marc R. Bomhof et al.
EUROPEAN JOURNAL OF NUTRITION (2019)
Connection between gut microbiome and the development of obesity
Cuiting Zhi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
Sang Bong Anh et al.
SCIENTIFIC REPORTS (2019)
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk et al.
EMBO MOLECULAR MEDICINE (2019)
Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
Ivana Milosevic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Gut microbial metabolites in obesity, NAFLD and T2DM
Emanuel E. Canfora et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity
Esther Nistal et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2019)
Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis
Brett R. Loman et al.
NUTRITION REVIEWS (2018)
Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
Fan Li et al.
SCIENCE CHINA-LIFE SCIENCES (2018)
The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
Abhasnee Sobhonslidsuk et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches
Antonella Borrelli et al.
REDOX BIOLOGY (2018)
Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study
Nazarii Kobyliak et al.
MINERVA MEDICA (2018)
Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics
Xiao Meng et al.
NUTRIENTS (2018)
Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Luigi Barrea et al.
NUTRIENTS (2018)
Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease
Monika Rau et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives
Juan P. Arab et al.
HEPATOLOGY (2017)
Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-omics-Based Approach
Federica Del Chierico et al.
HEPATOLOGY (2017)
Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial
Antje Micka et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2017)
Probiotics, gut microbiota, and their influence on host health and disease
Borja Sanchez et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis
Abed Zahedi Bialvaei et al.
JOURNAL OF CHEMOTHERAPY (2017)
Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial
Elina Manzhalii et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation
Da Zhou et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents
Fatemeh Famouri et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Glenn R. Gibson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis
Ceren Ozkul et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2017)
Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Da Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine
Wolfgang Stremmel et al.
PLOS ONE (2017)
Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
Da Zhou et al.
SCIENTIFIC REPORTS (2017)
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
Nathaniel Aviv Cohen et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study
Cyriac Abby Philips et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice
D. P. Singh et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial
Abbaszadeh Sepideh et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2016)
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Ron Sender et al.
CELL (2016)
Gut microbiota produce alcohol and contribute to NAFLD
Lixin Zhu et al.
GUT (2016)
Signals from the gut microbiota to distant organs in physiology and disease
Bjoern Schroeder et al.
NATURE MEDICINE (2016)
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Marialena Mouzaki et al.
PLOS ONE (2016)
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
Baohong Wang et al.
SCIENTIFIC REPORTS (2016)
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Douglas J. Morrison et al.
GUT MICROBES (2016)
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
A. Wieland et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function
Caleb J. Kelly et al.
CELL HOST & MICROBE (2015)
Brucellosis in Iran: Why Not Eradicated?
Hamed Ebrahimzadeh Leylabadlo et al.
CLINICAL INFECTIOUS DISEASES (2015)
Novel opportunities for next-generation probiotics targeting metabolic syndrome
Patrice D. Cani et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
An Tang et al.
DIABETES CARE (2015)
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Brian C. Ferslew et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Implications of microbiota and bile acid in liver injury and regeneration
Hui-Xin Liu et al.
JOURNAL OF HEPATOLOGY (2015)
Fecal microbiota transplantation broadening its application beyond intestinal disorders
Meng-Que Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
Weiwei Jiang et al.
SCIENTIFIC REPORTS (2015)
Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice
Jingjing Wang et al.
ISME JOURNAL (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Gut microbiome and nonalcoholic fatty liver diseases
Lixin Zhu et al.
PEDIATRIC RESEARCH (2015)
Gut microbiota and energy balance: role in obesity
Michael Blaut
PROCEEDINGS OF THE NUTRITION SOCIETY (2015)
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
W. H. Wilson Tang et al.
CIRCULATION RESEARCH (2015)
Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis
A. Alisi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials
Nicole J. Kellow et al.
BRITISH JOURNAL OF NUTRITION (2014)
Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease
S. Nabavi et al.
JOURNAL OF DAIRY SCIENCE (2014)
Gut Microbiota, Low-grade Inflammation, and Metabolic Syndrome
Benoit Chassaing et al.
TOXICOLOGIC PATHOLOGY (2014)
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Kouichi Miura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The interplay between the gut microbiota and the immune system
Markus B. Geuking et al.
GUT MICROBES (2014)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
An estimation of the number of cells in the human body
Eva Bianconi et al.
ANNALS OF HUMAN BIOLOGY (2013)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target
Luca Miele et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Tiphaine Le Roy et al.
GUT (2013)
Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease
Marialena Mouzaki et al.
HEPATOLOGY (2013)
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al.
HEPATOLOGY (2013)
Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice
Kouichi Miura et al.
HEPATOLOGY (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis - A Longitudinal Study
Vincent Wai-Sun Wong et al.
PLOS ONE (2013)
High-Fat Diet Reduces the Formation of Butyrate, but Increases Succinate, Inflammation, Liver Fat and Cholesterol in Rats, while Dietary Fibre Counteracts These Effects
Greta Jakobsdottir et al.
PLOS ONE (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?
Faming Zhang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis
Sabine Wagnerberger et al.
BRITISH JOURNAL OF NUTRITION (2012)
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression
Karen D. Corbin et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
Valentina Volynets et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
Functional interactions between the gut microbiota and host metabolism
Valentina Tremaroli et al.
NATURE (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms
Hua V. Lin et al.
PLOS ONE (2012)
Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme
Smaranda Craciun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
Melanie D. Spencer et al.
GASTROENTEROLOGY (2011)
Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells
Timea Csak et al.
HEPATOLOGY (2011)
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
Shani Ben-Shlomo et al.
JOURNAL OF HEPATOLOGY (2011)
Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms
Anna Iacono et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease
Pietro Vajro et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis
Gianluca Svegliati-Baroni et al.
LIVER INTERNATIONAL (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
The gut microbiome as therapeutic target
Patrice D. Cani et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Inflammasome is a central player in the induction of obesity and insulin resistance
Rinke Stienstra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Pathology of nonalcoholic fatty liver disease
Elizabeth M. Brunt
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Microbiota and SCFA in Lean and Overweight Healthy Subjects
Andreas Schwiertz et al.
OBESITY (2010)
High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse
Shengli Ding et al.
PLOS ONE (2010)
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Jill A. Parnell et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in the Liver of Young Rats
Emanuela Esposito et al.
JOURNAL OF NUTRITION (2009)
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski et al.
NATURE (2009)
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
F. Lirussi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease
C. P. Day
LIVER INTERNATIONAL (2006)
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Marc-Emmanuel Dumas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The gut flora as a forgotten organ
Ann M. O'Hara et al.
EMBO REPORTS (2006)
Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model
Jian-Gao Fan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases
C Loguercio et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Dietary fibres as prebiotics: Implications for colorectal cancer
CC Lim et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study
CA Daubioul et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2005)
Endogenous ethanol production in a child with short gut syndrome
BK Logan et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
ZP Li et al.
HEPATOLOGY (2003)
Obesity and female gender increase breath ethanol concentration: Potential implications for the pathogenesis of nonalcoholic steatohepatitis
S Nair et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis
AJ Wigg et al.
GUT (2001)
Increased gastrointestinal ethanol production in obese mice: Implications for fatty liver disease pathogenesis
K Cope et al.
GASTROENTEROLOGY (2000)
Obesity and female gender increase breath ethanol: Potential implications for the pathogenesis of nonalcoholic steatohepatitis.
S Nair et al.
GASTROENTEROLOGY (2000)
Share Paper
